High Tower Advisors, LLC Amgen Inc Put Options Transaction History

High Tower Advisors, LLC

11 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $10.9 Million - $11.8 Million	35,100 New	35,100 $11.3 Million
Q4 2023 Feb 12, 2024	BUY	$255.7 - $288.46 $204,560 - $230,767	800 New	800 $230,000
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $42,425 - $50,167	-198 Reduced 99.0%	2 $0
Q1 2023 May 11, 2023	BUY	$225.79 - $275.2 $44,706 - $54,489	198 Added 9900.0%	200 $48,000
Q4 2022 Feb 08, 2023	BUY	$229.03 - $291.01 $458 - $582	2 New	2 $0
Q1 2022 May 12, 2022	SELL	$219.27 - $242.57 $2,192 - $2,425	-10 Reduced 47.62%	11 $1,000
Q4 2021 Feb 10, 2022	SELL	$198.88 - $227.6 $373,695 - $427,660	-1,879 Reduced 98.89%	21 $34,000
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $63,681 - $74,610	300 Added 18.75%	1,900 $2,000
Q2 2021 Aug 06, 2021	BUY	$233.58 - $259.14 $369,289 - $409,700	1,581 Added 8321.05%	1,600 $1,000
Q1 2021 May 10, 2021	SELL	$221.91 - $258.6 $665 - $775	-3 Reduced 13.64%	19 $2,000
Q4 2020 Feb 10, 2021	BUY	$216.38 - $257.67 $4,760 - $5,668	22 New	22 $0

3,126

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $142B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.